NIH-funded research NIH-funded research

Targeting new molecular pathways to improve brain health after chronic reduced blood flow

Official title: Targeting novel molecular pathways to improve neurological outcomes after chronic hypoperfusion-induced ischemic brain injury

Funded at Veterans Health Administration · NIH-11412233 · Data updated 2026-11-12

A lab-led project tests new molecular targets to protect brain blood vessels and improve thinking skills in people affected by vascular brain injury due to long-term low blood flow.

More Brain Injury research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionVeterans Health Administration
NIH-funded
Lab location1 site (Pittsburgh, United States)
Project startOctober 1, 2026
Project endSeptember 30, 2030
Funding year2026
NIH project number1I01RD001196-01A1
Project IDNIH-11412233 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are individuals with vascular cognitive impairment or VCID, particularly veterans with chronic brain hypoperfusion-related injury.

Less likely to help

Patients without VCID or chronic hypoperfusion-related brain injury may not directly benefit.

What this research studies

This project focuses on how chronic cerebral hypoperfusion damages the brain's blood vessels and contributes to vascular cognitive impairment, aiming to find molecular targets that can preserve the blood-brain barrier and improve blood flow. Researchers will explore the roles of endothelial cells, microglia, and macrophages in inflammation and vascular integrity, and how salt-inducible kinases may influence these processes. The goal is to identify strategies that could slow cognitive decline in veterans with VCID by modulating inflammatory responses in the brain’s vasculature. The work is designed to translate basic findings into approaches that could eventually lead to therapies for people with acquired brain injury due to chronic hypoperfusion.

Why it matters

Potential benefit: If successful, the research could lead to therapies that protect brain blood vessels and slow cognitive decline in VCID patients.

How similar studies have gone: Previous studies support targeting neuroinflammation and vascular integrity as promising avenues, but this approach is exploratory and novel in the VCID context.

Where this research is happening

  • Veterans Health Administration
    Pittsburgh, United States
    Active

Researchers

  • Principal investigator: Chen, Jun — Veterans Health Administration
  • Study coordinator: Chen, Jun

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.